v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows - operating activities      
Net income $ 2,154 $ 2,050 $ 1,614
Less: Income (loss) from discontinued operations, net of taxes 0 0 (4)
Net income from continuing operations 2,154 2,050 1,618
Adjustments to reconcile Net income to Cash from (used for) operating activities – continuing operations:      
Depreciation of property, plant, and equipment 287 268 248
Amortization of intangible assets 291 312 362
Gain on remeasurement of Nihon Medi-Physics equity method investment (97) 0 0
Net periodic postretirement benefit plan (income) expense (267) (357) (332)
Postretirement plan contributions (338) (332) (357)
Share-based compensation 130 125 114
Provision for income taxes 614 531 743
Cash paid during the year for income taxes (429) (491) (474)
Changes in operating assets and liabilities, excluding the effects of acquisitions:      
Receivables (216) (157) (173)
Inventories (142) (81) 111
Contract and other deferred assets (60) 3 10
Accounts payable 90 60 (100)
Contract liabilities 81 68 26
Current compensation and benefits 94 39 153
All other operating activities – net (204) (83) 151
Cash from (used for) operating activities – continuing operations 1,987 1,955 2,101
Cash flows – investing activities      
Additions to property, plant and equipment and internal-use software (482) (401) (387)
Dispositions of property, plant, and equipment 0 0 1
Purchases of businesses, net of cash acquired (378) (313) (147)
Purchases of investments (118) (40) (48)
All other investing activities – net (69) (160) 23
Cash from (used for) investing activities – continuing operations (1,047) (914) (558)
Cash flows – financing activities      
Net increase (decrease) in borrowings (maturities of 90 days or less) 1 0 (12)
Newly issued debt, net of debt issuance costs (maturities longer than 90 days) 2,734 995 2,006
Repayments and other reductions (maturities longer than 90 days) (1,767) (1,418) (855)
Dividends paid to stockholders (64) (55) (41)
Repurchase of common stock (200) 0 0
Redemption of noncontrolling interests 0 0 (211)
Net transfers (to) from GE 0 0 (1,317)
Proceeds from stock issued under employee benefit plans 37 33 34
Taxes paid related to net share settlement of equity awards (42) (93) (33)
All other financing activities – net (81) (34) (49)
Cash from (used for) financing activities – continuing operations 617 (573) (478)
Cash from (used for) operating activities – discontinued operations 0 (4) 0
Effect of foreign currency rate changes on cash, cash equivalents, and restricted cash 66 (77) (10)
Increase (decrease) in cash, cash equivalents, and restricted cash 1,623 387 1,055
Cash, cash equivalents, and restricted cash at beginning of year 2,893 2,506 1,451
Cash, cash equivalents, and restricted cash at end of year 4,515 2,893 2,506
Supplemental disclosure of cash flows information      
Cash paid during the year for interest (522) (550) (570)
Non-cash investing activities      
Acquired but unpaid property, plant, and equipment $ 164 $ 143 $ 140